RFK Jr. Revamps CDC’s Vaccine Advisory Panel by Appointing OB-GYN Experts

RFK Jr. Revamps CDC’s Vaccine Advisory Panel by Appointing OB-GYN Experts

Health and Human Services Secretary Robert F. Kennedy Jr. took significant steps on Tuesday to reshape the CDC’s influential vaccine advisory panel. In a strategic move aimed at transforming immunization policies nationwide, he appointed two obstetrician-gynecologists to the Advisory Committee on Immunization Practices.

Kennedy, known for his long-standing skepticism towards vaccines, has made a commitment to the ‘Make America Healthy Again’ agenda. Among the newly appointed members are Dr. Adam Urato, a maternal-fetal medicine specialist, and Dr. Kimberly Biss, an OB-GYN operating out of St. Petersburg, Florida. Their expertise is expected to bring a different perspective to the committee, which plays a crucial role in federal vaccine recommendations.

Shifting the Focus on Vaccine Policy

Jim O’Neill, the acting director of the CDC and deputy secretary of health and human services, stated that these appointments are part of a larger initiative to ensure that vaccine policies are grounded in scientific evidence. “President Trump has tasked us with aligning the childhood immunization schedule with gold-standard science,” O’Neill explained. He emphasized that the new members possess the necessary clinical expertise to guide decisions based on evidence rather than preconceived notions.

Examining the Role of the Advisory Committee

The Advisory Committee on Immunization Practices, or ACIP, provides critical advice to both the CDC director and the HHS secretary regarding vaccine usage and the overall immunization schedule within the United States. This subgroup is pivotal in shaping health guidelines that impact American households.

In a notable action taken last June, Kennedy dismissed all existing members of the vaccination panel. He deemed this drastic step essential to restoring public trust and minimizing potential conflicts of interest. The reformed committee features appointees who align more closely with Kennedy’s views on vital issues such as vaccine safety, transparency, and scientific integrity.

Controversial Perspectives from New Appointees

Among the new appointments, Dr. Urato has previously raised concerns regarding the CDC’s COVID-19 vaccine recommendations for pregnant women. He contended that safety assurances were made prior to the availability of comprehensive data. While his supporters argue that Urato’s role is necessary for scrutinizing federal health guidelines, critics caution that it may erode public confidence in vaccines.

Major Changes to the Immunization Schedule

Since the new panel was instituted, members have revisited several traditional guidelines often supported by mainstream public health entities. One of the most significant outcomes was the revision of the CDC’s childhood immunization schedule earlier this year.

In January 2026, under the direction of the CDC and Kennedy’s administration, revisions were made to the U.S. childhood vaccine schedule. The number of vaccines recommended universally dropped from 17 to around 11. Notably, certain vaccines—such as flu, rotavirus, hepatitis A and B, several meningococcal vaccines, and RSV—are no longer broadly recommended, falling instead under shared decision-making frameworks or being advised only for specific high-risk groups.

Broader Health Initiatives Under the Trump Administration

Alongside these vaccine-related adjustments, the administration recently introduced new dietary guidelines that emphasize the consumption of high-quality proteins, healthy fats, fruits, vegetables, and whole grains. These guidelines urge Americans to steer clear of heavily processed foods and refined carbohydrates, reinforcing another core principle of Kennedy’s broader health initiative.

As RFK Jr. continues to shift the landscape of public health policy, the implications of these changes extend beyond the vaccine panel. By aligning the committee’s perspectives with his views, he aims to bring a new level of scrutiny and accountability to vaccine recommendations. The upcoming debates and discussions will likely center on the impact these new policies will have on public health and vaccine confidence across the nation.

Looking Ahead: The Future of Vaccine Policy

The restructured Advisory Committee on Immunization Practices represents a critical juncture in America’s public health policy. With an emphasis on both safety and scientific data, RFK Jr.’s latest appointments signal a potential transformation in how vaccines are regarded by the public and policymakers alike. As this story develops, stakeholders across the healthcare landscape will be watching closely to see how these decisions influence the nation’s approach to immunization.